In a rare firsthand account, Dr. Mohamed Ibrahim details his three-day escape from el-Fasher as paramilitary forces overran the city. His testimony paints a harrowing picture of urban warfare, civilian slaughter, and the systematic collapse of Sudan's last army bastion in Darfur.
Exclusive testimony from Dr. Mohamed Ibrahim, who fled the last hospital in Sudan's strategic el-Fasher, details a three-day ordeal of hiding from paramilitary forces, witnessing mass casualties, and surviving a kidnapping and ransom demand—shedding light on a siege the U.N. calls a 'massive crime scene.'
While America's coffee consumption hits multi-decade highs, Starbucks' market share is eroding. The pioneer now faces a crowded battlefield of value-focused rivals, drive-thru specialists, and international entrants, forcing a strategic rethink of its iconic 'third place' model.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
In a quiet corner of an Istanbul mosque, Iraqi master calligrapher Ali Zaman has concluded a six-year spiritual and artistic journey: the creation of what is believed to be the world's largest handwritten Quran. The monumental work highlights the enduring legacy of Islamic calligraphy, an art form that flourished under Ottoman patronage and continues to find a vibrant center in modern Turkey.
Amid a brutal year for apparel stocks, Deckers Outdoor delivered a stunning earnings beat, sending shares soaring 19%. The performance of its HOKA and UGG brands, coupled with raised guidance, suggests Wall Street's pessimism may have been overblown for this long-term winner.
QuantumScape's stock has plummeted 52% in three months, reigniting the debate over its valuation. While bulls point to a disruptive solid-state battery technology and a theoretical fair value of $55, skeptics highlight the absence of revenue and monumental scaling challenges. We examine the risks and rewards behind the volatility.
As AI data centers drive an unprecedented surge in U.S. power demand, natural gas producer EQT is positioning itself as a critical pillar of energy security. Its proven operational resilience during extreme weather events underscores a strategic shift from a pure commodity play to an essential infrastructure partner.
Danaher Corporation announces a strategic investment in Automata, aiming to integrate AI-ready automation systems with its extensive portfolio of instruments and reagents. The move signals a push to deliver comprehensive, data-driven lab solutions as the life sciences sector increasingly prioritizes efficiency and scalability.
Terreno Realty Corporation has completed a key industrial facility in Hialeah, Florida, part of a larger strategy to redevelop a former landfill into a premium logistics hub. The move highlights the firm's focus on coastal infill markets and raises questions about execution risks and valuation as the project scales up.
Despite a stellar 38% gain over the past year, analysis suggests Federated Hermes (NYSE: FHI) shares may still be trading at a discount to their intrinsic value, presenting a potential opportunity in the capital markets sector.
Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.
Zoom Video Communications' early investment in AI powerhouse Anthropic is emerging as a critical, and potentially undervalued, component of its growth story, prompting analysts and investors to reassess the company's long-term trajectory beyond video conferencing.
General Motors is cutting over 700 positions at its Oshawa, Ontario plant, redirecting investment and workforce development to its U.S. facilities. The move underscores a strategic realignment of North American operations amid evolving trade dynamics and a focus on core truck and SUV programs.
Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.
Tilray Brands deepens its commitment to Europe's regulated medical cannabis sector with the launch of Tilray Medical Italia, a strategic venture with local partner Molteni Farmaceutici. The move comes as the company seeks to stabilize its growth narrative amid significant stock market volatility.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
RH shares have slumped roughly 13% over the past week, contrasting sharply with strong gains over the prior month. This pullback places the luxury home furnishings retailer under a valuation microscope, with analysts debating whether the dip presents a buying opportunity or signals deeper challenges ahead.
USA Rare Earth secures a landmark $1.6 billion in federal loans and equity, coupled with a $1.5 billion private placement, to build a domestic supply chain from Texas mines to Oklahoma magnets, reducing reliance on China for critical defense and green tech components.
Mondelez International merges its financial and operational leadership under CFO Luca Zaramella, a move analysts say aims to tighten cost control and execution amid intense competition and commodity pressures.
